Moderna will not enforce Covid-19 vaccine patents during pandemic

Moderna is not asserting its intellectual property rights for its vaccine technology and is willing to license the technology behind its experimental coronavirus vaccine after the pandemic, the company said in a statement.

Moderna vaccine, Moderna vaccine study, US vaccine study, Coronavirus vaccine, Covid vaccine study, world news, Indian express

The FDA said on Monday the idea of changing the authorized dosing or schedules of COVID-19 vaccines was premature and not supported by available data.

Moderna Inc said on Thursday it would not enforce patents related to its experimental COVID-19 vaccine while the pandemic continues, a move that would allow other drugmakers to develop shots using the company’s technology.

Moderna is not asserting its intellectual property rights for its vaccine technology and is willing to license the technology behind its experimental coronavirus vaccine after the pandemic, the company said in a statement.

The company is one of the furthest along in the US race for a vaccine seen as essential to ending a pandemic that has claimed more than a million lives worldwide.

Moderna has received over $1 billion in government funding to develop and produce its candidate, and another $1.5 billion to supply it to the American public.

First uploaded on: 08-10-2020 at 18:56 IST

Tags:
Moderna

Heermandi: There’s nothing to applaud in non-consensual sex

EntertainmentUpdated: May 3, 2024 19:05 IST

Sanjay Leela Bhansali's school of filmmaking is known for its maximalism and beautiful actresses in intricate jewellery and costumes. In his first web series, Heeramandi, Bhansali introduces us to the world of 'tawaifs' or courtesans. While these women are portrayed as powerful decision-makers, the reality is far from it.

View all shorts

Live Blog